Pearls & Oy-sters: CNS lymphoma in a patient with relapsing-remitting multiple sclerosis treated with interferon

Neurology. 2017 Oct 24;89(17):e210-e213. doi: 10.1212/WNL.0000000000004579.

Authors

Sharon Chiang¹, Navin K Kesari¹, Anthony Bradshaw¹, Wendy Chen¹, Rohini Samudralwar¹, Ammar M Alobaidy¹, Joseph S Kass²

Affiliations

¹ From the School of Medicine (S.C.) and Department of Neurology (N.K.K., A.B., W.C., R.S., A.M.A., J.S.K.), Baylor College of Medicine, Houston, TX.
² From the School of Medicine (S.C.) and Department of Neurology (N.K.K., A.B., W.C., R.S., A.M.A., J.S.K.), Baylor College of Medicine, Houston, TX. kass@bcm.edu.

No abstract available

Publication types

Case Reports

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Brain Neoplasms / complications
Brain Neoplasms / diagnosis*
Brain Neoplasms / diagnostic imaging
Brain Neoplasms / drug therapy
Diagnosis, Differential
Female
Humans
Interferon beta-1a / adverse effects*
Interferon beta-1a / therapeutic use
Lymphoma / complications
Lymphoma / diagnosis*
Lymphoma / diagnostic imaging
Lymphoma / drug therapy
Middle Aged
Multiple Sclerosis, Relapsing-Remitting / diagnosis*
Multiple Sclerosis, Relapsing-Remitting / diagnostic imaging
Multiple Sclerosis, Relapsing-Remitting / drug therapy

Substances

Interferon beta-1a